Despite the advance in surgical technique with less invasive procedures, breast cancer (BC) surgery is still associated with moderate to severe postoperative pain (PP) that can impede recovery on postoperation (
1). To decrease PP control, opioid requirement, outcome improvement, and side effect decrease, regional anesthesia or preoperative analgesia is routinely performed as an alternative to general anesthesia (
2,
3). Minimizing analgesic-related adverse effects, as well as maximizing PP relief, is vital to postoperative patients’ recovery (
4). Preoperative analgesia for BC surgery consumes significant quantities of opioids compared to cosmetic breast surgeries. Thoracic wall nerve blocks, such as pectoral nerves (PECS) block, have recently become popular for preoperative pain control in patients undergoing BC surgery (
5). Ultrasound-guided (US) modified PECS initially described for cosmetic BC surgeries provides excellent analgesia (
1). It has been shown that thoracic paravertebral block in combination with general anesthesia improves the quality of recovery (
6,
7). Several clinical trials have shown the positive results of analgesic drugs in the PECS block in BC surgery. However, it has been recently shown that the PECS block does not effectively block the sensory nerves nor does it exert additional analgesic effects.